ArticleScientific reports2026
Phytochemical profiling of Rosmarinus officinalis aerial parts and exploring its in vitro wound healing activity and network pharmacology.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Therapeutic effects of Rosmarinus officinalis against methotrexate-induced submandibular salivary gland injury in male albino rats.Journal of molecular histology · 2026Article
- Unlocking the Potential ofFoods (Basel, Switzerland) · 2026Review
- Organ-Specific Phytochemical Profiles, Wound-Healing and Hemostatic Activities ofMolecules (Basel, Switzerland) · 2026Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The present study thoroughly assessed the wound healing efficacy of fractions derived from Rosmarinus officinalis through phytochemical profiling, antioxidant assays, and in vitro scratch wound models, along with network pharmacology to identify target genes. HPLC/MS analysis identified rosmarinic acid as the predominant phenolic compound, alongside diterpenoids (carnosic acid, carnosol) and flavonoids (cirsimaritin, diosmetin). The total extract exhibited the highest total phenolic content (106.56 µg gallic acid eq/mg), while the ethyl acetate fraction (ROE) contained the highest flavonoids (43.7 µg rutin eq/mg). Antioxidant assays revealed fraction-dependent efficacy: the n-butanol fraction (RON) showed superior (Ferric Reducing Antioxidant Power) FRAP activity (637.727 µM TE/mg), whereas ROE demonstrated potent radical scavenging (DPPH (2,2-diphenyl-1-picrylhydrazyl) IC₅₀: 22.81 µg/mL; ABTS (2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) IC₅₀: 33.6 µg/mL). In vitro scratch assays on human skin fibroblasts (HSF) highlighted ROE and RON as the most effective fractions, reducing wound widths to 0.42 ± 0.04 mm and 0.41 ± 0.005 mm, respectively, within 24 h at 10 µg/mL. These fractions also suppressed LPS(Lipopolysaccharide)-induced nitric oxide production in macrophages by > 70%, underscoring anti-inflammatory synergies. Furthermore, utilising network pharmacology, we identified ten hub target genes associated with wound healing, including IL6 and 1B (Interleukin‑6, -1B), TNF (Tumor Necrosis Factor) and FN1(Fibronectin 1). The findings establish that solvent polarity critically influences bioactive compound recovery, with semi-polar fractions (ROE, RON) optimally balancing antioxidant, anti-inflammatory, and fibroblast-migratory properties for wound healing applications. As a conclusion, R. officinalis is a great natural candidate for valuable bioactive components with promising anti-inflammatory, wound healing, and antioxidant properties. Further phytochemical studies should be performed to isolate the responsible compounds and investigate their mechanism of action.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.